Ferring will acquire Gameto, an IVF technology startup, in a deal worth up to $1.4 billion, according to BioPharma Dive. The buyout gives Ferring access to a technology that could make the in vitro fertilisation process less complex and demanding for patients.
This deal is notable for its size and focus on innovation in a tightly regulated industry. Senior executives in pharma and biotech should watch how this acquisition may shift the competitive field in IVF and influence future technology investments.
